Hyperkalemia with Mineralocorticoid Receptor Antagonist Use in People with CKD: Understanding and Mitigating the Risks.

Authors :: Epstein M
Pecoits-Filho R
Clase CM
Sood MM
Kovesdy CP
Source :: Clinical journal of the American Society of Nephrology : CJASN [Clin J Am Soc Nephrol] 2022 Mar; Vol. 17 (3), pp. 455-457. Date of Electronic Publication: 2021 Dec 01.
Publication Year :: 2022

Subjects :: Angiotensin-Converting Enzyme Inhibitors
Female
Humans
Male
Mineralocorticoid Receptor Antagonists adverse effects
Spironolactone
Hyperkalemia chemically induced
Renal Insufficiency, Chronic complications

Full Text Access

Tools